Your browser doesn't support javascript.
loading
Patient Factors Influencing Respiratory-Related Clinician Actions in Chronic Obstructive Pulmonary Disease Screening.
Wadland, William C; Zubek, Valentina Bayer; Clerisme-Beaty, Emmanuelle M; Ríos-Bedoya, Carlos F; Yawn, Barbara P.
Afiliación
  • Wadland WC; Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan. Electronic address: william.wadland@hc.msu.edu.
  • Zubek VB; Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
  • Clerisme-Beaty EM; Medical Affairs Clinical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
  • Ríos-Bedoya CF; Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan.
  • Yawn BP; Department of Research, Olmsted Medical Center, Rochester, Minnesota.
Am J Prev Med ; 52(1): 94-99, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27617368
ABSTRACT

INTRODUCTION:

The purpose of this study was to identify patient-related factors that may explain the increased likelihood of receiving a respiratory-related clinician action in patients identified to be at risk for chronic obstructive pulmonary disease in a U.S.-based pragmatic study of chronic obstructive pulmonary disease screening.

METHODS:

This post hoc analysis (conducted in 2014-2015) of the Screening, Evaluating and Assessing Rate Changes of Diagnosing Respiratory Conditions in Primary Care 1 (SEARCH1) study (conducted in 2010-2011), used the chronic obstructive pulmonary disease Population Screener questionnaire in 112 primary care practices. Anyone with a previous chronic obstructive pulmonary disease diagnosis was excluded. Multivariate logistic regression modeling was used to assess patient factors associated with the likelihood of receiving an respiratory-related clinician action following positive screening.

RESULTS:

Overall, 994 of 6,497 (15%) screened positive and were considered at risk for chronic obstructive pulmonary disease. However, only 187 of the 994 patients (19%) who screened positive received a respiratory-related clinician action. The chances of receiving a respiratory-related clinician action were significantly increased in patients who visited their physician with a respiratory issue (p<0.05) or had already been prescribed a respiratory medication (p<0.05). Most (81%) patients who screened positive or had a respiratory-related clinician action had one or more comorbidity, including cardiovascular disease (68%), diabetes (30%), depression/anxiety (26%), asthma (11%), and cancer (9%).

CONCLUSIONS:

Routine chronic obstructive pulmonary disease screening appears to promote respiratory-related clinician actions in patients with a high likelihood for disease who have respiratory complaints or already use prescribed respiratory medication.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamizaje Masivo / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamizaje Masivo / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2017 Tipo del documento: Article